These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32291496)
1. Exploring the anti-stress effects of imatinib and tetrabenazine in cold-water immersion-induced acute stress in mice. Kumar M; Singh N; Jaggi AS Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1625-1634. PubMed ID: 32291496 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological investigations on adaptation in rats subjected to cold water immersion stress. Agrawal A; Jaggi AS; Singh N Physiol Behav; 2011 Jun; 103(3-4):321-9. PubMed ID: 21324329 [TBL] [Abstract][Full Text] [Related]
3. Investigations on GSK-3β/NF-kB signaling in stress and stress adaptive behavior in electric foot shock subjected mice. Bali A; Jaggi AS Behav Brain Res; 2016 Apr; 302():1-10. PubMed ID: 26778780 [TBL] [Abstract][Full Text] [Related]
4. Investigating the stress attenuating potential of furosemide in immobilization and electric foot-shock stress models in mice. Kaur A; Bali A; Singh N; Jaggi AS Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):497-507. PubMed ID: 25604076 [TBL] [Abstract][Full Text] [Related]
6. Anti-stress effects of a GSK-3β inhibitor, AR-A014418, in immobilization stress of variable duration in mice. Bali A; Jaggi AS J Basic Clin Physiol Pharmacol; 2017 Jul; 28(4):315-325. PubMed ID: 28590916 [TBL] [Abstract][Full Text] [Related]
7. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769 [TBL] [Abstract][Full Text] [Related]
8. Anti-stress effects of cilnidipine and nimodipine in immobilization subjected mice. Kumar N; Singh N; Jaggi AS Physiol Behav; 2012 Mar; 105(5):1148-55. PubMed ID: 22210395 [TBL] [Abstract][Full Text] [Related]
9. Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex. Kitanaka N; Kitanaka J; Hall FS; Kandori T; Murakami A; Muratani K; Nakano T; Uhl GR; Takemura M Pharmacol Biochem Behav; 2018 Sep; 172():9-16. PubMed ID: 30017858 [TBL] [Abstract][Full Text] [Related]
10. Opening of T-type Ca2+ channels and activation of HCN channels contribute in stress adaptation in cold water immersion stress-subjected mice. Kaur S; Singh N; Jaggi AS Life Sci; 2019 Sep; 232():116605. PubMed ID: 31254588 [TBL] [Abstract][Full Text] [Related]
11. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809 [TBL] [Abstract][Full Text] [Related]
12. Investigations in foot shock stress of variable intensity in mice: Adaptation and role of angiotensin II. Bali A; Jaggi AS Eur J Pharmacol; 2015 Aug; 761():86-94. PubMed ID: 25941079 [TBL] [Abstract][Full Text] [Related]
13. Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine. Ugolev Y; Segal T; Yaffe D; Gros Y; Schuldiner S J Biol Chem; 2013 Nov; 288(45):32160-32171. PubMed ID: 24062308 [TBL] [Abstract][Full Text] [Related]
14. Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action. Huang M; He W; Rajagopal L; Kudwa A; Grigoriadis DE; Meltzer HY Pharmacol Biochem Behav; 2020 Mar; 190():172872. PubMed ID: 32084491 [TBL] [Abstract][Full Text] [Related]
15. Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other? Stahl SM CNS Spectr; 2018 Aug; 23(4):239-247. PubMed ID: 30160230 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement]. Machida K; Kawakami D; Miki M Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):144-51. PubMed ID: 24614638 [No Abstract] [Full Text] [Related]
17. Effects of adrenal medulla graft on recovery of GABAergic and dopaminergic neuron deficits in mice: behavioural, pharmacological and immunohistochemical study. Jousselin-Hosaja M; Tobin C; Venault P; Joubert C; Chapouthier G Behav Brain Res; 2003 Mar; 140(1-2):185-93. PubMed ID: 12644291 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy offers HD patients relief from some symptoms. Tetrabenazine inhibits the transport of a molecule called vesicular monoamine transporter type 2 or VMAT2. Morrow T Manag Care; 2008 Nov; 17(11):46-7. PubMed ID: 19052001 [No Abstract] [Full Text] [Related]